Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001789769-26-000032
Filing Date
2026-04-24
Accepted
2026-04-24 16:22:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14aproxyadditional2026.htm DEFA14A 10047
2 GRAPHIC notice1.jpg GRAPHIC 219574
3 GRAPHIC notice2.jpg GRAPHIC 140290
  Complete submission text file 0001789769-26-000032.txt   506874
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40215 | Film No.: 26894420
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)